Sarcoplasmic Hypertrophy: Is Early Muscle Growth Real?

Six weeks into a new hypertrophy block, a lifter's arm measures bigger, the mirror looks different, and the obvious conclusion is that the muscle has grown. A biopsy taken at that exact moment would tell a stranger story. Some of that size increase is new contractile machinery. Some of it might be fluid, glycogen, and sarcoplasmic protein with no force-producing function at all. Untangling the two is the subject of one of hypertrophy science's odder arguments: sarcoplasmic hypertrophy.

Why This Matters

Most lifters use visible size, a tape measure, or a progress photo as the scoreboard for whether training is working. That feedback loop assumes every centimetre gained is equivalent: more muscle, more force capacity, more strength potential. The research below complicates that assumption. Cross-sectional area can increase substantially without a matching increase in the contractile proteins, actin and myosin, that actually generate force¹. If a meaningful share of early "growth" is water, glycogen, and non-contractile protein rather than more muscle-fibre machinery, then the tape measure is a noisier signal than most people assume, particularly in the first weeks of a new programme.

This matters for how a wearable like ZELOS should be read against what shows up in the mirror. Surface EMG measures neural drive and recruitment, the muscle actually working set to set, independent of whether the tissue underneath is in the middle of a damage-and-swelling cycle or genuinely adding contractile protein. The two signals are not measuring the same thing, and conflating them leads to some avoidable confusion about what "progress" looks like early in a training block.

The Study That Started the Argument

The modern debate traces largely to a single trial. Haun and colleagues put 15 trained men through six weeks of high-volume resistance training and biopsied their vastus lateralis before and after¹. Mean fibre cross-sectional area rose 23%, a substantial and statistically solid result. But when the researchers looked at what was actually inside those larger fibres, the picture shifted. Concentrations of actin and myosin, the proteins that generate contractile force, fell by roughly 30% from pre- to post-training. Sarcoplasmic protein content, by contrast, rose 66%, and mitochondrial density (via citrate synthase activity) dropped 24%.

In plain terms: the fibres got bigger, but a larger share of that new space was filled with non-contractile fluid and protein rather than more force-generating machinery. The authors labelled this pattern "sarcoplasmic hypertrophy," borrowing a term that had circulated in bodybuilding culture for decades but had rarely been tested directly against biopsy data.

Timing Is Everything: When Does Growth Become Real?

A separate line of work, largely from Felipe Damas and colleagues, points at a related but distinct problem: early-training cross-sectional area gains often reflect muscle damage and oedema rather than any form of hypertrophy at all, sarcoplasmic or otherwise. In a ten-week trial with biopsies at weeks one, three, and ten, fibre cross-sectional area correlated strongly with the rate of myofibrillar protein synthesis (r ≈ 0.9) at weeks three and ten, but showed no such relationship at week one⁴. The first-week size increase was there, but it wasn't tracking real muscle-building activity. It was more consistent with the fluid shift that follows unaccustomed muscle damage.

A follow-up review from the same group proposed a rough timeline: for untrained lifters, the first four or so sessions produce size increases driven mostly by damage-induced swelling, and measurable true hypertrophy, the kind backed by sustained myofibrillar protein accretion, typically doesn't show up until somewhere around the eighteenth session⁵, roughly six weeks of training three times a week. Before that point, muscle damage is not what drives long-term growth; it is a confound that inflates early measurements and then fades as the muscle adapts to the new stimulus.

This creates two separate reasons to distrust an early size increase as a training-quality signal: it might be damage-driven swelling that will settle back down, or it might be genuine hypertrophy that is disproportionately sarcoplasmic rather than contractile. Neither a tape measure nor an untrained eye can tell the two apart.

The Myonuclei Threshold

Underneath both processes sits the question of myonuclei, the DNA-containing structures that support protein synthesis within a muscle fibre and are added by satellite cells during growth. A systematic review and meta-analysis of 27 studies and 903 participants found that myonuclear addition can occur even with modest fibre hypertrophy of 10% or less, contradicting an older idea that a fixed "myonuclear domain ceiling" had to be reached before new nuclei were recruited⁷. The same analysis found a clearly larger jump in myonuclei number once hypertrophy reached roughly 22%, suggesting the relationship is graded rather than a hard threshold.

Separately, satellite cell content itself rises within 48 hours of a person's very first resistance training session, well before any hypertrophy is detectable, and stays elevated across a ten-week programme⁸. Critically, that early satellite cell response was not immediately coupled to new myonuclei. The remodelling process appears to unfold in stages: damage and cellular signalling first, satellite cell proliferation next, and only later, if the stimulus continues, actual myonuclear addition and myofibrillar growth. Sarcoplasmic expansion, on this reading, may reflect an intermediate stage of that sequence rather than a separate, competing pathway.

A Contested Category

Not every researcher accepts sarcoplasmic hypertrophy as a distinct, meaningful adaptation. A 2025 review directly challenged the concept, arguing that the evidence for sarcoplasmic expansion as a functionally significant, separate category of muscle growth is weaker than the original single study suggested³. The critique centres on measurement: most muscle-thickness or cross-sectional-area methods used in training research (ultrasound, MRI, even the original biopsy-based fibre measurements) cannot reliably separate contractile from non-contractile volume changes without the kind of detailed proteomic analysis Haun's team performed, and that analysis has not been widely replicated.

Adding to the complication, a trial that used concentric-only training, deliberately minimising the eccentric muscle damage thought to drive early swelling, still produced real lean mass and muscle thickness increases within four weeks⁶. Lean mass rose by over 100 grams and muscle thickness increased by two to three millimetres across the study, despite the near-absence of the damage mechanism that Damas's group implicates in early, unreliable size gains. That result doesn't disprove sarcoplasmic hypertrophy, but it does show that early adaptation isn't purely a damage-and-swelling artefact either. Multiple processes appear to be running in parallel, and the field has not fully separated them.

Individual variability compounds the uncertainty. A trial that systematically varied resistance training programme design across eight weeks in trained men found that between-person variability in both myofibrillar protein synthesis rate and cross-sectional area change was roughly 40 times larger than the variability introduced by the training manipulations themselves². Two people running an identical programme can show dramatically different combinations of contractile and sarcoplasmic growth, for reasons that have little to do with which programme they followed.

What This Means in Practice

None of this means early training progress is fake or that size changes don't matter. It means the tape measure and the mirror are answering a different question than "is my training working." A wearable that reads muscle activation and effort at the point of contraction is measuring something more immediate: whether the target muscle was recruited, how hard it worked relative to prior sessions, and whether output held up across a set. That signal doesn't depend on whether the tissue underneath is mid-way through a damage-and-remodelling cycle.

The practical takeaway for a lifter starting a new block, a new exercise, or a new muscle group is patience with the visual feedback loop specifically. A jump in arm size in week two is plausible, expected, and not necessarily evidence of new contractile tissue. The recruitment and effort signal from a session, by contrast, is available immediately and doesn't need six weeks of remodelling to become meaningful. Training decisions, such as whether a set was productive or whether load should increase, are better made from that immediate signal than from watching a tape measure that may be reporting oedema as often as adaptation.

Key Takeaways

Six weeks of high-volume training can increase muscle fibre size by over 20% while the concentration of force-generating contractile protein inside those fibres actually falls, with sarcoplasmic (non-contractile) protein rising in its place¹.

Cross-sectional area gains in the first week of a new programme often don't track real muscle-building activity and are more consistent with damage-induced swelling than genuine hypertrophy⁴.

True, sustained myofibrillar hypertrophy typically isn't detectable until roughly eighteen training sessions in, about six weeks at a normal training frequency⁵.

Whether sarcoplasmic hypertrophy is a distinct, functionally meaningful adaptation or a measurement artefact is genuinely contested in the literature, not settled science³.

Differences between individuals in how much of their growth is contractile versus sarcoplasmic dwarf the differences produced by tweaking a training programme, which is one reason two lifters on the same plan can look so different at the same time point².

References

1. Haun, C. T., Vann, C. G., Osburn, S. C., Mumford, P. W., Roberson, P. A., Romero, M. A., Fox, C. D., Johnson, C. A., Parry, H. A., Kavazis, A. N., Moon, J. R., Badisa, V. L. D., Mwashote, B. M., Ibeanusi, V., Young, K. C., & Roberts, M. D. (2019). Muscle fiber hypertrophy in response to 6 weeks of high-volume resistance training in trained young men is largely attributed to sarcoplasmic hypertrophy. PLoS ONE, 14(6), e0215267. https://doi.org/10.1371/journal.pone.0215267

2. Damas, F., Angleri, V., Phillips, S. M., Witard, O. C., Ugrinowitsch, C., Santanielo, N., Soligon, S. D., Costa, L. A. R., Lixandrão, M. E., Conceição, M. S., & Libardi, C. A. (2019). Myofibrillar protein synthesis and muscle hypertrophy individualized responses to systematically changing resistance training variables in trained young men. Journal of Applied Physiology, 127(3), 806-815. https://doi.org/10.1152/japplphysiol.00350.2019

3. Van Every, D. W., Lees, M. J., Wilson, B., Nippard, J., & Phillips, S. M. (2025). Load-induced human skeletal muscle hypertrophy: Mechanisms, myths, and misconceptions. Journal of Sport and Health Science, 15, 101104. https://doi.org/10.1016/j.jshs.2025.101104

4. Damas, F., Phillips, S. M., Libardi, C. A., Vechin, F. C., Lixandrão, M. E., Jannig, P. R., Costa, L. A. R., Bacurau, A. V., Snijders, T., Parise, G., Tricoli, V., Roschel, H., & Ugrinowitsch, C. (2016). Resistance training-induced changes in integrated myofibrillar protein synthesis are related to hypertrophy only after attenuation of muscle damage. The Journal of Physiology, 594(18), 5209-5222. https://doi.org/10.1113/JP272472

5. Damas, F., Libardi, C. A., & Ugrinowitsch, C. (2018). The development of skeletal muscle hypertrophy through resistance training: the role of muscle damage and muscle protein synthesis. European Journal of Applied Physiology, 118(3), 485-500. https://doi.org/10.1007/s00421-017-3792-9

6. Stock, M. S., Mota, J. A., DeFranco, R. N., Grue, K. A., Jacobo, A. U., Chung, E., Moon, J. R., DeFreitas, J. M., & Beck, T. W. (2017). The time course of short-term hypertrophy in the absence of eccentric muscle damage. European Journal of Applied Physiology, 117(5), 989-1004. https://doi.org/10.1007/s00421-017-3587-z

7. Conceição, M. S., Vechin, F. C., Lixandrão, M., Damas, F., Libardi, C. A., Tricoli, V., Roschel, H., Camera, D., & Ugrinowitsch, C. (2018). Muscle fiber hypertrophy and myonuclei addition: A systematic review and meta-analysis. Medicine & Science in Sports & Exercise, 50(7), 1385-1393. https://doi.org/10.1249/MSS.0000000000001593

8. Damas, F., Libardi, C. A., Ugrinowitsch, C., Vechin, F. C., Lixandrão, M. E., Snijders, T., Nederveen, J. P., Bacurau, A. V., Brum, P., Tricoli, V., Roschel, H., Parise, G., & Phillips, S. M. (2018). Early- and later-phases satellite cell responses and myonuclear content with resistance training in young men. PLoS ONE, 13(1), e0191039. https://doi.org/10.1371/journal.pone.0191039